Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia
Conclusions:
TMS is a noninvasive procedure that reliably distinguishes AD from FTD and HC and, if these findings are replicated in larger studies, could represent a useful additional diagnostic tool for clinical practice.
Classification of evidence:
This study provides Class III evidence that TMS measures can distinguish patients with AD from those with FTD.
Source: Neurology - Category: Neurology Authors: Benussi, A., Di Lorenzo, F., Dell'Era, V., Cosseddu, M., Alberici, A., Caratozzolo, S., Cotelli, M. S., Micheli, A., Rozzini, L., Depari, A., Flammini, A., Ponzo, V., Martorana, A., Caltagirone, C., Padovani, A., Koch, G., Borroni, B. Tags: Diagnostic test assessment, Alzheimer's disease, TMS, Frontotemporal dementia, Assessment of cognitive disorders/dementia ARTICLE Source Type: research